Showing 1 to 1 of 1 results
theguardian.com
🌐 85% Global Worthiness


AstraZeneca's $1 Billion Acquisition of EsoBiotec Expands Cancer Immunotherapy Portfolio
AstraZeneca, Britain's largest listed pharmaceutical company, acquired Belgian biotech EsoBiotec for $1 billion to expand its cancer immunotherapy portfolio, offering faster and more cost-effective treatments; this follows other recent acquisitions and positive drug development news.
AstraZeneca's $1 Billion Acquisition of EsoBiotec Expands Cancer Immunotherapy Portfolio
AstraZeneca, Britain's largest listed pharmaceutical company, acquired Belgian biotech EsoBiotec for $1 billion to expand its cancer immunotherapy portfolio, offering faster and more cost-effective treatments; this follows other recent acquisitions and positive drug development news.
Progress
40% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results